These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 36465729)

  • 1. A Case of COVID-Associated Nephropathy (COVAN).
    Craig T; Ansari M; Foster P; Abdelgadir Y; Abdelghani A; Jha P
    Cureus; 2022 Oct; 14(10):e30872. PubMed ID: 36465729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of COVID-19-associated collapsing glomerulopathy: 22 months of follow-up.
    Gandhi P; Dowling CS; Satoskar A; Shah A
    Clin Nephrol Case Stud; 2023; 11():110-113. PubMed ID: 37485073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19-Related Glomerulopathy: A Report of 2 Cases of Collapsing Focal Segmental Glomerulosclerosis.
    Magoon S; Bichu P; Malhotra V; Alhashimi F; Hu Y; Khanna S; Berhanu K
    Kidney Med; 2020; 2(4):488-492. PubMed ID: 32775989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Analysis of the Kidney From a Patient With COVID-19-Associated Collapsing Glomerulopathy.
    Meliambro K; Li X; Salem F; Yi Z; Sun Z; Chan L; Chung M; Chancay J; Vy HMT; Nadkarni G; Wong JS; Fu J; Lee K; Zhang W; He JC; Campbell KN
    Kidney Med; 2021; 3(4):653-658. PubMed ID: 33942030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19-Associated Collapsing Focal Segmental Glomerulosclerosis: A Report of 2 Cases.
    Sharma Y; Nasr SH; Larsen CP; Kemper A; Ormsby AH; Williamson SR
    Kidney Med; 2020; 2(4):493-497. PubMed ID: 32775990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronavirus disease 2019-associated nephropathy in an African American patient: a case report and review of the literature.
    Dhillon VS; Alkashash A; Viquez-Beita K
    J Med Case Rep; 2023 Apr; 17(1):153. PubMed ID: 37024977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19-Associated Nephropathy: A Devastating Complication.
    Kim A; Mahgoub A; Parajuli A; Towfiq B
    Cureus; 2023 Aug; 15(8):e43558. PubMed ID: 37719542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-associated nephropathy: experimental models.
    Avila-Casado C; Fortoul TI; Chugh SS
    Contrib Nephrol; 2011; 169():270-285. PubMed ID: 21252526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APOL1-Associated Collapsing Focal Segmental Glomerulosclerosis in a Patient With Stimulator of Interferon Genes (STING)-Associated Vasculopathy With Onset in Infancy (SAVI).
    Abid Q; Best Rocha A; Larsen CP; Schulert G; Marsh R; Yasin S; Patty-Resk C; Valentini RP; Adams M; Baracco R
    Am J Kidney Dis; 2020 Feb; 75(2):287-290. PubMed ID: 31601430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Rare Case of Granulomatous Interstitial Nephritis in a Patient With COVID-19.
    Alotaibi M; Ellis C; Wadhwani S; Peleg Y
    J Investig Med High Impact Case Rep; 2022; 10():23247096221114517. PubMed ID: 35906762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collapsing Focal Segmental Glomerulosclerosis in Viral Infections.
    Muehlig AK; Gies S; Huber TB; Braun F
    Front Immunol; 2021; 12():800074. PubMed ID: 35095882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor's APOL1 Risk Genotype and "Second Hits" Associated With De Novo Collapsing Glomerulopathy in Deceased Donor Kidney Transplant Recipients: A Report of 5 Cases.
    Chang JH; Husain SA; Santoriello D; Stokes MB; Miles CD; Foster KW; Li Y; Dale LA; Crew RJ; Cohen DJ; Kiryluk K; Gharavi AG; Mohan S
    Am J Kidney Dis; 2019 Jan; 73(1):134-139. PubMed ID: 30054024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential Role of High-Dose Steroids in the Treatment of COVID-19-Associated Nephropathy.
    Kadariya K; Soji-Ayoade D; Isaac S; Paul S
    Cureus; 2023 Feb; 15(2):e35372. PubMed ID: 36974231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collapsing glomerulopathy in a young woman with APOL1 risk alleles following acute parvovirus B19 infection: a case report investigation.
    Besse W; Mansour S; Jatwani K; Nast CC; Brewster UC
    BMC Nephrol; 2016 Sep; 17(1):125. PubMed ID: 27600725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APOL1 risk variants and the development of HIV-associated nephropathy.
    Goyal R; Singhal PC
    FEBS J; 2021 Oct; 288(19):5586-5597. PubMed ID: 33340240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FSGS and COVID-19 in Non-African American Patients.
    Medina E; Rueda C; Batlle D
    Kidney360; 2023 May; 4(5):687-699. PubMed ID: 37229730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Similarities and Differences between COVID-19-Associated Nephropathy and HIV-Associated Nephropathy.
    Chen A; Yin L; Lee K; He JC
    Kidney Dis (Basel); 2022 Jan; 8(1):1-12. PubMed ID: 35127839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APOL1 localization in normal kidney and nondiabetic kidney disease.
    Madhavan SM; O'Toole JF; Konieczkowski M; Ganesan S; Bruggeman LA; Sedor JR
    J Am Soc Nephrol; 2011 Nov; 22(11):2119-28. PubMed ID: 21997392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19-related collapsing glomerulopathy revealing a rare risk variant of APOL1: lessons for the clinical nephrologist.
    Laboux T; Gibier JB; Pottier N; Glowacki F; Hamroun A
    J Nephrol; 2021 Apr; 34(2):373-378. PubMed ID: 33548053
    [No Abstract]   [Full Text] [Related]  

  • 20. Apolipoprotein L1 (APOL1) Variants (Vs) a possible link between Heroin-associated Nephropathy (HAN) and HIV-associated Nephropathy (HIVAN).
    Lan X; Rao TK; Chander PN; Skorecki K; Singhal PC
    Front Microbiol; 2015; 6():571. PubMed ID: 26106375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.